Correlation Engine 2.0
Clear Search sequence regions


  • BARX1 (4)
  • cancers (4)
  • CNAs (1)
  • cohort (1)
  • DLX4 (4)
  • gene (1)
  • human (1)
  • patients (2)
  • poor prognosis (1)
  • prognostic (2)
  • renal cell carcinoma (2)
  • Sun (1)
  • western blot (1)
  • Sizes of these terms reflect their relevance to your search.

    Dysregulation of transcription factors contributes to the carcinogenesis and progression of cancers. However, their roles in clear cell renal cell carcinoma remain largely unknown. This study aimed to evaluate the clinical significance of TFs and investigate their potential molecular mechanisms in ccRCC. Data were accessed from the cancer genome atlas kidney clear cell carcinoma cohort. Bioinformatics algorithm was used in copy number alterations mutations, and differentially expressed TFs' analysis. Univariate and multivariate Cox regression analyses were performed to identify clinically significant TFs and construct a six-TF prognostic panel. TFs' expression was validated in human tissues. Gene set enrichment analysis (GSEA) was utilized to find enriched cancer hallmark pathways. Functional experiments were conducted to verify the cancer-promoting effect of BARX homeobox 1 (BARX1) and distal-less homeobox 4 (DLX4) in ccRCC, and Western blot was performed to explore their downstream pathways. As for results, many CNAs and mutations were identified in transcription factor genes. TFs were differentially expressed in ccRCC. An applicable predictive panel of six-TF genes was constructed to predict the overall survival for ccRCC patients, and its diagnostic efficiency was evaluated by the area under the curve (AUC). BARX1 and DLX4 were associated with poor prognosis, and they could promote the proliferation and migration of ccRCC. In conclusion, the six-TF panel can be used as a prognostic biomarker for ccRCC patients. BARX1 and DLX4 play oncogenic roles in ccRCC via promoting proliferation and epithelial-mesenchymal transition. They have the potential to be novel therapeutic targets for ccRCC. Copyright © 2021 Sun, Ge, Zhang, Yan, Wu, Ouyang, Wang, Ding, Zhang, Long, Liu, Shi, Zhou, Chen and Ye.

    Citation

    Guoliang Sun, Yue Ge, Yangjun Zhang, Libin Yan, Xiaoliang Wu, Wei Ouyang, Zhize Wang, Beichen Ding, Yucong Zhang, Gongwei Long, Man Liu, Runlin Shi, Hui Zhou, Zhiqiang Chen, Zhangqun Ye. Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition. Frontiers in molecular biosciences. 2021;8:626328


    PMID: 34124141

    View Full Text